Lexicon Pharmaceuticals
LXRX
#6223
Rank
โ‚น98.10 B
Marketcap
โ‚น220.86
Share price
-0.85%
Change (1 day)
187.63%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2025 (TTM): -โ‚น16.40

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น18.09. In 2024 the company made an earnings per share (EPS) of -โ‚น60.93 an increase over its 2023 EPS that were of -โ‚น76.16.

EPS history for Lexicon Pharmaceuticals from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น16.40-73.08%
2024-โ‚น60.93-20%
2023-โ‚น76.1631.15%
2022-โ‚น58.07-0%
2021-โ‚น58.0710.91%
2020-โ‚น52.36-145.08%
2019โ‚น116.14-206.09%
2018-โ‚น109.48-5.74%
2017-โ‚น116.14-10.95%
2016-โ‚น130.422640%
2015-โ‚น4.76-96.34%
2014-โ‚น129.91-2.53%
2013-โ‚น133.28-9.09%
2012-โ‚น146.61

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
โ‚น1,735-9,689.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น526.46-3,010.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น4,049-22,484.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-โ‚น581.67 3,115.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น599.76-3,415.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-โ‚น47.60 163.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-โ‚น71.40 294.74%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น133.28-836.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚น7,303 40,273.68%๐Ÿ‡บ๐Ÿ‡ธ USA